Endpoints for Neuroprotection in Glaucoma Trials - Ora Clinical

EN | JPN | FR

Expertise
Experience is everything. We’re 100% dedicated to ophthalmology. It’s all we do.  And with over 3,000 clinical ophthalmology projects completed, our teams are not just experts — they’re THE experts.

Explore our Clinical Expertise
Retina, Glaucoma, Refractive & CED

Dry Eye & Ocular Surface

Allergy & Blepharitis

Medical Device
Clinical Success
Blueprint for success

For over 45+ years, we’ve helped bring over 85 drugs and devices to market. We have the right people, processes and technology to streamline research and development and deliver the highest quality results.

Learn About Our Approach

Site Solutions

Safety & Monitoring

Data & Biostatistics

Clinical Tools & Processes

Regulatory Approach

Ora Endpoints & Technologies
Global Reach
Expanding across the globe.

With access to 1000+ sites across 50+ countries, we’re conducting research with unique patient populations around the globe.

View Global Footprint
North America

South America

Europe

Asia/Pacific
About Ora
The Ora Way

Leadership Team

Careers

Blind Canvas Project
Resources
Contact

Endpoints for Neuroprotection in Glaucoma Trials

This webinar delves into new clinical approaches and endpoints for glaucoma therapies, focusing on IOP-independent neuroprotection. It covers recent research, FDA considerations, and strategies to optimize therapeutic programs for glaucoma patients.